Abstract: PO0769
Impact of Non-Pharmacological Interventions in Indigenous Populations with Diabetes Mellitus on Cardiovascular and Kidney Disease: A Scoping Review Using the REAIM Framework
Session Information
- Diabetic Kidney Disease: Clinical
November 04, 2021 | Location: On-Demand, Virtual Only
Abstract Time: 10:00 AM - 12:00 PM
Category: Diabetic Kidney Disease
- 602 Diabetic Kidney Disease: Clinical
Authors
- Okpechi, Ikechi G., University of Alberta Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada
- Muneer, Shezel, University of Alberta Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada
- Tinwala, Mohammed M., University of Alberta Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada
- Ghimire, Anukul, University of Alberta Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada
- Khan, Maryam, University of Alberta Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada
- Sultana, Naima, University of Alberta Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada
- Ye, Feng, University of Alberta Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada
- Zaidi, Deenaz, University of Alberta Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada
- Bello, Aminu K., University of Alberta Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada
Background
Diabetes mellitus is a common cause of mortality from cardiovascular (CV) and kidney diseases. This scoping review utilized the RE-AIM (reach, efficacy, adoption, implementation, and maintenance) framework to assess the impact of non-pharmacological interventions on CV and kidney health outcomes (KHO) in Indigenous populations
Methods
We searched Medline, Embase, Cochrane Library, CINAHL, Web of Science, PsycINFO and other grey literature to identify studies that used non-pharmacological interventions (exercise, nutrition, telehealth, educational, health worker, and cultural) to achieve improved glycaemic control, and reduction of clinical or laboratory markers of CV or KHO in Indigenous communities
Results
Our search yielded 7,692 studies, from which 35 studies were selected. Culturally appropriate interventions were mostly utilized (77.1%); telehealth programs were least utilized (8.6%). Clinical and laboratory indices of CV and KHO were infrequently assessed (KHO assessed in 40%); improved kidney function was reported in 10.5% of health worker interventions. (Table 1). Reporting of items of the RE-AIM framework showed that internal validity items were more frequently reported than those of external validity: reach (60%), efficacy (52.1%), adoption (46.1%), implementation (41.9%), and maintenance (37.2%) (Table 2)
Conclusion
Due to the high prevalence of CV and kidney diseases in diabetic patients of Indigenous groups, studies using diabetes interventions need to report more items of external validity to allow the findings of such interventions to be translatable into practice
Table 1
Table 2